Dow Inc. Shares Surge 3.4% on Q1 Earnings Beat and Signs of Margin Recovery
Dow Inc. (DOW) shares rose 3.41% in pre-market trading Thursday after the company reported a narrower-than-expected first-quarter loss and signaled that profit margins began to recover in March. While the materials science leader posted an operating loss of $0.14 per share, the result significantly outperformed the $0.26 loss anticipated by Wall Street, as aggressive cost-cutting and a massive litigation windfall offset geopolitical headwinds.
Earnings Beat Amid Macro Volatility
Dow Inc. delivered a resilient first-quarter performance, reporting a non-GAAP operating loss of $0.14 per share, which beat the consensus estimate of a $0.26 loss by $0.12. On a GAAP basis, the company reported a net loss of $445 million, or $0.74 per share. The discrepancy between GAAP and operating results was largely driven by a $0.60 per share adjustment related to the Sadara guarantee liability and taxes from litigation proceeds.
Net sales for the quarter came in at $9.8 billion, a 6% decline compared to the same period last year, but still ahead of the $9.66 billion analysts had projected. The revenue drop was attributed to a 7% decline in local pricing and a 2% dip in overall volumes, primarily due to the ongoing conflict in the Middle East and planned maintenance at U.S. Gulf Coast facilities.
The 'March Inflection' and Supply Chain Dynamics
Despite the year-over-year declines, CEO Jim Fitterling provided a bullish outlook on the company's trajectory. Fitterling noted that the margin backdrop began to "positively inflect" in March. This recovery was paradoxically supported by global supply constraints stemming from the Middle East conflict, which tightened the market and allowed Dow to leverage its advantaged U.S. manufacturing footprint.
"The strength of Dow’s advantaged portfolio is a clear differentiator," Fitterling said in the release. Analysts noted that Dow’s ethane-based production in the Americas provides a structural cost advantage over naphtha-based competitors in Europe and Asia, particularly as disruptions in the Strait of Hormuz have pressured global supply chains.
Cash Flow Windfall and Segment Performance
One of the most striking figures in the report was the surge in cash provided by operating activities, which reached $1.1 billion—a $1.0 billion increase over the previous year. This was almost entirely driven by the receipt of a major payment from NOVA Chemicals related to long-standing litigation. The total proceeds from the NOVA settlement reached approximately $1.3 billion (CAD $1.8 billion), providing a significant liquidity cushion.
Segment performance remained mixed:
- Packaging & Specialty Plastics: Reported net sales of $4.9 billion, down 7% year-over-year. While polyethylene volumes saw gains, they were offset by lower merchant olefins sales and lower integrated margins.
- Industrial Intermediates & Infrastructure: Sales fell 8% to $2.6 billion, heavily impacted by volume declines in Polyurethanes due to the Middle East conflict.
- Performance Materials & Coatings: Remained relatively flat, showing resilience in a difficult environment.
Strategic Shifts and Outlook
Dow also announced a significant accounting change, suspending the recognition of equity losses from its Sadara joint venture. The company stated that the carrying value of these liabilities has reached the total of its existing obligations, a move that analysts say will simplify the company's profit and loss statement moving forward.
Looking ahead, the company remains focused on its "Transform to Outperform" initiative, which aims for $2 billion in near-term EBITDA improvements. With the stock trading at $39.61 in the pre-market, investors appear to be betting that the March margin recovery marks the beginning of a cyclical upturn for the chemical giant.
Key Takeaways
- Non-GAAP EPS loss of $0.14 beat the consensus estimate of -$0.26 by $0.12.
- Net sales of $9.8 billion exceeded expectations of $9.66 billion, despite a 6% year-over-year decline.
- Operating cash flow surged to $1.1 billion, bolstered by a $1.3 billion litigation settlement from NOVA Chemicals.
- CEO Jim Fitterling highlighted a positive margin inflection starting in March, driven by global supply constraints.
- The company suspended Sadara equity loss recognition, simplifying future financial reporting.